Clinical trial Recruiting at 1 site Interventional Ages 0 Days to 14 Days

Sodium-guided Fortification for growth in very preterm infants

Official title: Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm Infants

Run by University of Washington · NCT07562997 · Data updated 2026-11-12

In very preterm babies, this study tests whether guiding milk fortification with urine and blood sodium tests helps them grow and gain lean mass better than standard fortified milk.

Quick facts

Study typeInterventional
Ages0 Days to 14 Days
SexAll
Enrollment150 (estimated)
SponsorUniversity of Washington
Academic / other
Locations3 sites (Cincinnati, Ohio and 2 other locations)
StatusRecruiting
StartedMay 18, 2026
Main results expectedJune 1, 2029
Study endsOctober 31, 2029
Registry record updatedMay 28, 2026
Trial IDNCT07562997 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants born between 24+0 and 31+6 weeks gestation, admitted to participating NICUs, and who have achieved full enteral feeding.

Probably not a fit

Infants with congenital anomalies affecting growth, significant renal dysfunction, NEC grade 2 or higher, limited NICU stay, or enrollment in conflicting interventional studies may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a urine sodium-guided supplementation protocol with the standard enriched fortification approach in very preterm infants. Starting around day 14 of life and continuing until about 38 weeks postmenstrual age, researchers monitor urine and serum sodium to tailor electrolyte and fortification needs. The goal is to improve body growth and lean mass by addressing early sodium depletion due to immature kidney function. Outcomes include anthropometric measures and body composition assessments. The trial is conducted across three NICUs with predefined inclusion and exclusion criteria.

Why it matters

Potential benefit: If successful, the approach could improve growth and lean mass in very preterm infants by optimizing sodium balance.

How similar studies have gone: Urine sodium-guided approaches have shown potential in identifying sodium depletion earlier than serum testing, with some prospective data supporting improved growth signals, but this specific protocol is novel in validating body composition outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Admitted to the University of Washington, Oregon Health and Sciences, or University of Cincinnati NICU at 14 days of age
* Born between 24w0days and 31w6d
* Achieved full enteral feeding

Exclusion Criteria:

* Congenital or chromosomal anomalies affecting growth
* Acute renal insufficiency (KDIGO stage 1 or higher)
* Necrotizing enterocolitis (modified Bell's stage IIA or higher)
* Anticipated NICU stay less than 30 days
* Enrollment in a concurrent interventional study that may confound study outcomes

Where it's running

  • University of Washington
    Seattle, Washington, United States
    Recruiting
  • University of Cincinnati
    Cincinnati, Ohio, United States
    Not yet recruiting
  • Oregon Health & Science University
    Portland, Oregon, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Katie Strobel, MD, MSCR — University of Washington
  • Study coordinator: John Feltner, MS
  • Email: jfeltner@uw.edu
  • Phone: (206) 543-3200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.